GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $602,000 | +88.1% | 8,846 | +19.6% | 0.00% | +200.0% |
| Q4 2020 | $320,000 | -80.9% | 7,394 | -75.6% | 0.00% | -87.5% |
| Q3 2020 | $1,672,000 | -83.9% | 30,319 | -81.6% | 0.01% | -84.0% |
| Q2 2020 | $10,402,000 | +1116.6% | 164,767 | +884.9% | 0.05% | +900.0% |
| Q1 2020 | $855,000 | -33.0% | 16,729 | +4.1% | 0.01% | -16.7% |
| Q4 2019 | $1,277,000 | +63.9% | 16,065 | 0.0% | 0.01% | +50.0% |
| Q3 2019 | $779,000 | -7.8% | 16,065 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $845,000 | -36.3% | 16,065 | -35.9% | 0.01% | -28.6% |
| Q1 2019 | $1,326,000 | +28.5% | 25,055 | -0.4% | 0.01% | +16.7% |
| Q4 2018 | $1,032,000 | -18.4% | 25,145 | -24.5% | 0.01% | -14.3% |
| Q3 2018 | $1,265,000 | -61.3% | 33,300 | -53.9% | 0.01% | -61.1% |
| Q2 2018 | $3,268,000 | +869.7% | 72,300 | +935.8% | 0.02% | +800.0% |
| Q1 2018 | $337,000 | – | 6,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |